7,9-Substituted tetracycline compounds

7, 9-substituierte Tetracyclin-Verbindungen

Composés de tétracycline substitués en position 7, 9


A 7, 9-substituted tetracycline compound of Formula I: wherein: X is CH 2 ; R 4' and R 4" are each independently alkyl; R 4 is NR 4' R 4" ; R 2 , R 2' , R 3 , R 8 , R 10 , R 11 and R 12 are each hydrogen; R 5 is hydrogen or hydroxyl; R 7 is nitro; R 9 is alkyl, alkenyl, alkynyl, aryl, alkoxy, alkylthio, alkylsulfinyl, alkylsulfonyl, arylalkyl, amino, arylalkenyl, arylalkynyl, thionitroso, acyl or-(CH 2 ) 0-3 NR 9c (=Z')ZR 9a ; Z is CR 9d R 9e , S, NR 9b or O; Z' is O, S or NR 9f ; and R 9a , R 9b , R 9c , R 9d , R 9e and R 9f are each independently hydrogen, acyl, alkyl, alkenyl, alkynyl, alkoxy, alkylthio, alkylsulfinyl, alkylsulfonyl, alkylamino, arylalkyl, aryl, heterocyclic or heteroaromatic.




Download Full PDF Version (Non-Commercial Use)

Patent Citations (19)

    Publication numberPublication dateAssigneeTitle
    DE-2346535-A1April 11, 1974Farmaceutici ItaliaVerfahren zur herstellung von tetracyclin-derivaten und dabei erhaltene produkte
    DE-2527568-A1January 15, 1976Farmaceutici ItaliaVerfahren zur herstellung von alkyltetracyclinen und neue tetracyclinderivate
    US-2980584-AApril 18, 1961Pfizer & Co CParenteral magnesium oxytetracycline acetic or lactic acid carboxamide vehicle preparation
    US-2990331-AJune 27, 1961Pfizer & Co CStable solutions of salts of tetracyclines for parenteral administration
    US-3062717-ANovember 06, 1962Pfizer & Co CIntramuscular calcium tetracycline acetic or lactic acid carboxamide vehicle preparation
    US-3165531-AJanuary 12, 1965Pfizer & Co C13-substituted-6-deoxytetracyclines and process utilizing the same
    US-3338963-AAugust 29, 1967American Cyanamid CoTetracycline compounds
    US-3433834-AMarch 18, 1969American Cyanamid CoNitration of 11a-chloro tetracyclines
    US-3454697-AJuly 08, 1969American Cyanamid CoTetracycline antibiotic compositions for oral use
    US-3557280-AJanuary 19, 1971Koninklijke Gist SpiritusStable solutions of oxytetracycline suitable for parenteral and peroral administration and process of preparation
    US-3674859-AJuly 04, 1972PfizerAqueous doxycycline compositions
    US-3957980-AMay 18, 1976Pfizer Inc.Doxycycline parenteral compositions
    US-4018889-AApril 19, 1977Pfizer Inc.Oxytetracycline compositions
    US-4024272-AMay 17, 1977Merck Patent Gesellschaft Mit Beschrankter HaftungTetracyclic compounds
    US-4126680-ANovember 21, 1978Pfizer Inc.Tetracycline antibiotic compositions
    US-5532227-AJuly 02, 1996The Research Foundation Of State University Of New YorkTetracyclines including non-antimicrobial chemically-modified tetracyclines inhibit excessive glycosylation of different types of collagen and other proteins during diabetes
    US-5789395-AAugust 04, 1998The Research Foundation Of State University Of New York, Hospital For Joint DiseasesMethod of using tetracycline compounds for inhibition of endogenous nitric oxide production
    US-5834450-ANovember 10, 1998Pfizer Inc.9- (substituted amino) -alpha-6-deoxy-5-oxy tetracycline derivatives, their preparation and their use as antibiotics
    WO-0028983-A1May 25, 2000Collagenex Pharmaceuticals, Inc.Nouveaux derives de 4-dedimethy laminotetra cycline

NO-Patent Citations (3)

    BERGE ET AL.: "Pharmaceutical Salts", J PHARM. SCI., vol. 66, 1977, pages 1 - 19
    VAN DER BOZERT ET AL., CANCER RES., vol. 48, 1988, pages 6686 - 6690
    WAITZ, J.A.: "National Commission for Clinical Laboratory Standards, Document M7-A2", vol. 10, 1990, pages: 13 - 20

Cited By (0)

    Publication numberPublication dateAssigneeTitle